DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr | ₹1,950 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹4,507 Cr |
Mar2023 | ₹2,183 Cr |
Mar2022 | ₹1,952 Cr |
Mar2021 | ₹2,026 Cr |
Mar2020 | ₹1,950 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹4,507 Cr | 106.52 | |
Mar2023 | ₹2,183 Cr | 11.83 | |
Mar2022 | ₹1,952 Cr | -3.67 | |
Mar2021 | ₹2,026 Cr | 3.90 | |
Mar2020 | ₹1,950 Cr | - |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,079.6 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,090.3 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -0.2% |
9.5% |
12.8% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses